Document Detail


Metformin lowers the threshold for stress-induced senescence: A role for the microRNA-200 family and miR-205.
MedLine Citation:
PMID:  22356767     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
We have tested the hypothesis that the antidiabetic biguanide metformin can be used to manipulate the threshold for stress-induced senescence (SIS), thus accelerating the onset of cancer-protective cellular senescence in response to oncogenic stimuli. Using senescence-prone murine embryonic fibroblasts (MEFs), we assessed whether metformin treatment modified the senescence phenotype that is activated in response to DNA damaging inducers. Metformin significantly enhanced the number of MEFs entering a senescent stage in response to doxorubicin, an anthracycline that induces cell senescence by activating DNA damage signaling pathways (e.g., ATM/ATR) in a reactive oxygen species (ROS)-dependent manner. Using WI-38 and BJ-1 human diploid fibroblasts (HDFs), we explored whether metformin supplementation throughout their entire replicative lifespan may promote the early appearance of the biomarkers of replicative senescence. Chronic metformin significantly reduced HDFs' lifespan by accelerating both the loss of replicative potential and the acquisition of replicative senescence-related biomarkers (e.g., enlarged and flattened cell shapes, loss of arrayed arrangement, accumulation of intracellular and extracellular debris and SA-β-gal-positive staining). Metformin functioned as a bona fide stressful agent, inducing monotonic, dose-dependent, SIS-like responses in BJ-1 HDFs, which are highly resistant to ROS-induced premature senescence. Metformin-induced SIS in BJ-1 fibroblasts was accompanied by the striking activation of several microRNAs belonging to the miR-200s family (miR-200a, miR-141 and miR429) and miR-205, thus mimicking a recently described ability of ROS to chemosensitize cancer cells by specifically upregulating anti-EMT (epithelial-to-mesenchymal transition) miR-200s. Because the unlimited proliferative potential of stem cells results from their metabolic refractoriness to SIS, we finally tested if metformin treatment could circumvent the stress (e.g., ROS)-resistant phenotype of induced pluripotent stem cells (iPSCs). Metformin treatment drastically reduced both the number and the size of iPSC colonies and notably diminished the staining of the pluripotency marker alkaline phosphatase. Our current findings, altogether, reveal for the first time that metformin can efficiently lower the threshold for SIS to generate an "stressed" cell phenotype that becomes pre-sensitized to oncogenic-like stimuli, including DNA damaging, proliferative and/or stemness inducers.
Authors:
Sílvia Cufí; Alejandro Vazquez-Martin; Cristina Oliveras-Ferraros; Rosa Quirantes; Antonio Segura-Carretero; Vicente Micol; Jorge Joven; Joaquim Bosch-Barrera; Sonia Del Barco; Begoña Martin-Castillo; Luciano Vellon; Javier A Menendez
Related Documents :
22681417 - Effects of wax treatment on the physiology and cellular structure of harvested pineappl...
8184257 - Lymphokine-activated killer cells induce differentiation in mcf-7 breast carcinoma nodu...
22306777 - Hypoxic stress activates chaperone-mediated autophagy and modulates neuronal cell survi...
22682957 - Fabricated cantilever for afm measurements and manipulations: pre-stress analysis of st...
11215767 - Carbohydrate moieties of the interstitial and glandular tissues of the amphibian pleuro...
15698797 - A new route to trihydroxamate-containing artificial siderophores and synthesis of a new...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-3-15
Journal Detail:
Title:  Cell cycle (Georgetown, Tex.)     Volume:  11     ISSN:  1551-4005     ISO Abbreviation:  -     Publication Date:  2012 Mar 
Date Detail:
Created Date:  2012-2-27     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101137841     Medline TA:  Cell Cycle     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Affiliation:
Translational Research Laboratory; Catalan Institute of Oncology; Girona, Catalonia, Spain; Girona Biomedical Research Institute; Girona, Catalonia, Spain; These authors have equally contributed to this research and are listed in random order.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Translational control of cell fate: From integration of environmental signals to breaching anticance...
Next Document:  Phospho-?Np63?-dependent regulation of autophagic signaling through transcription and micro-RNA modu...